Search results
Added:
9 months ago
EuroPCR 25 - A meta-analysis of the individual patient data from the PROTECTED TAVR and BHF PROTECT-TAVI studies show TAVI with cerebral embolic protection (CEP) may reduce the rate of disabling stroke compared to TAVI without CEP.We are joined by Prof Rajesh Kharbanda (Oxford Radcliffe Hospitals NHS Trust, Oxford, UK) to discuss outcomes from a meta-analysis investigating TAVI with or without…
View more
Added:
6 months ago
Explore the intricate challenges of TAVR-in-TAVR procedures with Dr Frederick Welt, addressing the growing need for repeat transcatheter interventions as TAVR expands to younger patient populations.This comprehensive presentation, part of the Complex Cases track, examines the technical and clinical considerations when managing structural valve deterioration in patients with existing transcatheter…
View more
Added:
6 months ago
Master the technical complexities of TAVR-in-TAVR procedures with Dr Mohamed MarwanThis essential presentation tackles implanting a transcatheter valve within a previously implanted, failing TAVR device. As first-generation TAVR patients return for treatment, Dr Marwan provides the critical knowledge needed to master these increasingly common complex procedures.Key technical considerations…
View more
TCT 23: WATCH-TAVR
Added:
2 years ago
Video
Added:
2 years ago
In this insightful interview, investigator, Prof Raj R Makkar(Cedars-Sinai Heart Institute, US) joins us to discuss the outcomes of repeat transcatheter aortic valve replacement with balloon-expandable valves.
Prof Makkar and his team used the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry to address a series of questions regarding the safety…
View more
Added:
11 months ago
ACC 2025 - Primary findings from EARLY-TAVR show the benefit of early TAVR intervention was consistent across biomarker subgroups.Dr Brian Lindman (Vanderbilt University Medical Center, Nashville, US) joins us onsite at ACC 2025 to discuss findings from the primary biomarker analysis from the EARLY TAVR trial (NCT03042104; Edwards Lifesciences). The analysis investigated cardiac biomarkers in…
View more
Added:
1 year ago
TCT Conference 2024 - Safety and efficacy outcomes of transcatheter aortic valve replacement (TAVR) in addition to optimal heart failure therapy (OHFT) compared to OHFT alone in patients with heart failure and moderate aortic stenosis.Dr Nicolas M Van Mieghem (Erasmus University Medical Center, Rotterdam, NL) joins us onsite at TCT Conference to discuss the findings from TAVR UNLOAD (NCT02661451)…
View more
Added:
7 months ago
Navigate the complexities of patient-prosthesis mismatch (PPM) in transcatheter aortic valve replacement with Dr Dee Dee Wang, exploring the critical distinctions that will shape 2025 clinical practice.This comprehensive presentation dissects the three distinct types of PPM, moving beyond traditional definitions to examine the real-world challenges facing interventional cardiologists today. Dr…
View more
Added:
8 months ago
New York Valves 25 - Dr Tanush Gupta (UVM Medical Center, Burlington, VT, US) joins us to discuss key conversations around lifetime management for transcatheter aortic valve replacement (TAVR) patients. He discusses key data from the NOTION trial and how this has influenced his practice, as well emerging technologies such as AI simulation models and new valves.Interview Questions:How has FDA…
View more
Added:
6 months ago
Navigate the complex landscape of coronary interventions following transcatheter aortic valve replacement with Dr Samineh Sehatbakhsh, addressing critical access challenges in an era of expanding TAVR indications.This essential presentation, part of the Complex Cases track, examines the growing clinical significance of post-TAVR coronary access as procedures expand to younger, lower-risk patients…
View more